Structure-activity relationship studies of QS11, a small molecule Wnt synergistic agonist.


Journal Article

Both the Wnt/β-catenin signaling pathway and small GTPases of the ADP-ribosylation factors (ARF) family play important roles in regulating cell development, homeostasis and fate. The previous report of QS11, a small molecule Wnt synergist that binds to ARF GTPase-activating protein 1 (ARFGAP1), suggests a role for ARFGAP1 in the Wnt/β-catenin pathway. However, direct inhibition of enzymatic activity of ARFGAP1 by QS11 has not been established. Whether ARFGAP1 is the only target that contributes to QS11's Wnt synergy is also not clear. Here we present structure-activity relationship (SAR) studies of QS11 analogs in two assays: direct inhibition of enzymatic activity of purified ARFGAP1 protein and cellular activation of the Wnt/β-catenin pathway. The results confirm the direct inhibition of ARFGAP1 by QS11, and also suggest the presence of other potential cellular targets of QS11.

Full Text

Cited Authors

  • Singh, MK; Gao, H; Sun, W; Song, Z; Schmalzigaug, R; Premont, RT; Zhang, Q

Published Date

  • November 2015

Published In

Volume / Issue

  • 25 / 21

Start / End Page

  • 4838 - 4842

PubMed ID

  • 26152429

Pubmed Central ID

  • 26152429

Electronic International Standard Serial Number (EISSN)

  • 1464-3405

International Standard Serial Number (ISSN)

  • 0960-894X

Digital Object Identifier (DOI)

  • 10.1016/j.bmcl.2015.06.062


  • eng